Evidence map›Paper›PMID 36947517›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in

Shanshan Guo, Shuang Zhang, Yixiao Zhuang, Famin Xie, Ruwen Wang, Xingyu Kong, Qiongyue Zhang, Yonghao Feng, Huanqing Gao, Xingxing Kong and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Aging and cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Poly (ADP-Ribose) Glycohydrolase-Dependent dePARylation of PCNA Is Essential for DNA Replication.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shanshan GuoState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-0393-2914
Shuang ZhangSchool of Exercise and Health, Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport, Shanghai, 200438, China.ORCID 0000-0001-8414-6741
Yixiao ZhuangState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-3566-2162
Famin XieState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-2055-8346
Ruwen WangSchool of Exercise and Health, Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport, Shanghai, 200438, China.ORCID 0000-0001-9328-5137
Xingyu KongState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-1441-1241
Qiongyue ZhangDepartment of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, China.ORCID 0000-0001-6914-2849
Yonghao FengDepartment of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, China.ORCID 0000-0002-2585-5203
Huanqing GaoState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0002-8567-3583
Xingxing KongState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0002-8395-0268
Tiemin LiuState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0003-2077-7653
Fudan University · CNShanghai University of Sport · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(ADP-ribose) polymerase-1 (PARP1) has been reported to play an important role in longevity. Here, we showed that the knockdown of the PARP1 extended the lifespan of

Indexed as

Drosophila ProteinsPoly (ADP-Ribose) Polymerase-1Poly ADP RibosylationAMP-Activated Protein KinasesAnimalsDrosophilaLongevityMusclesProtein Serine-Threonine KinasesPTEN-Induced Putative KinaseAMP-Activated Protein KinasesDrosophila ProteinsParp protein, DrosophilaPINK1 protein, DrosophilaPoly (ADP-Ribose) Polymerase-1Protein Serine-Threonine KinasesPTEN-Induced Putative KinaselongevitymitochondriaPARP1PARylation

Identifiers

PMID36947517
PMCPMC10068811
OpenAlexW4353021648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.